Skip to main content
India's Trade & Customs Knowledge Base
Live on PostgreSQL About• Contact• Sign in Subscribe
EK EXIMKEY
Export · Import · Customs · DGFT Intelligence
Circular

NOTIFICATION NO. 01/2021, DT. 11/04/2021

Document type
Circular
Dated

Amendment in Export Policy of Injection Remdesivir and Remdesivir API.

NOTIFICATION NO. 01/2021, DT. 11/04/2021

Amendment in Export Policy of Injection Remdesivir and Remdesivir API.

 

S.O. 1548(E).—In exercise of powers conferred by Section 3 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy, 2015-20, the Central Government hereby makes the following amendment in Schedule 2 of the ITCHS Export policy related to export of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API):
 

S. No. ITC HS Codes Description Present Policy Revised Policy
207AA Ex 293499
Ex 300490
Injection Remdesivir and Remdesivir

Active Pharmaceutical Ingredients(API)
Free Prohibited


2. The provision under Para 1.05 of the Foreign Trade Policy (FTP) 2015-20 regarding transitional arrangement is not applicable for this notification.

3. Effect of this Notification:

The export of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) falling under the ITCHS Codes specified above or falling under any other HS Code has been prohibited, with immediate effect.

[F. No. 01/91/180/24/AM-22/EC/E-27724]
 

AMIT YADAV,

Director General of Foreign Trade
Ex-Officio Additional Secretary,Government of India
Email:dgft@nic.in

Related Content

48,405
HS Codes covered
Section to 8-digit product level
37,765
Regulatory documents
DGFT, Customs, Excise, RBI & GST
152,183
Import duty lines
Tariff lines with effective rates
20,499
SION norms
Standard input–output norms